2021-05-11T12:16:32-05:00 2020-09-30 366055558 GRANT THORNTON LLP 100 E WISCONSIN AVE MILWAUKEE WI 53202 990 2019-10-01 411704734 BE THE MATCH FOUNDATION BETH 7634068700 500 N 5TH ST MINNEAPOLIS MN 554011206 AMY RONNEBERG CEO 7634068694 2021-05-10 1 MICHELLE L WEBER P00556798 4142898200 2021-05-10 2019 2022-09-23 18:48:47Z JOY KING 500 N 5TH ST MINNEAPOLIS MN 554011206 20062542 0 X WWW.BETHEMATCH.ORG X 1991 MN FUNDRAISING TO SUPPORT MISSION OF THE NMDP/BE THE MATCH: SAVE LIVES THROUGH CELLULAR THERAPY. 18 17 41 354 0 0 10751245 18034650 0 0 868271 474694 -540428 -234956 11079088 18274388 9991185 8077451 0 0 3987185 3818929 786942 615139 1314037 2152680 953128 16917992 13464647 -5838904 4809741 16248451 17220560 9689455 5533636 6558996 11686924 X BE THE MATCH IS A GLOBAL LEADER WORKING EVERY DAY TO SAVE LIVES THROUGH CELLULAR THERAPY. FOR PEOPLE WITH LIFE-THREATENING BLOOD CANCERS-LIKE LEUKEMIA AND LYMPHOMA-OR OTHER BLOOD DISORDERS LIKE SICKLE CELL, A CURE EXISTS. BE THE MATCH (CONTINUED ON SCHEDULE O) 0 0 4813025 4813025 PATIENT ASSISTANCE - BE THE MATCH FOUNDATION (BTMF) PROVIDES FINANCIAL ASSISTANCE TO PATIENTS THROUGHOUT EACH STAGE OF THE TRANSPLANT PROCESS. FUNDED FULLY BY PHILANTHROPY, MORE THAN $4.8 MILLION WAS PROVIDED TO PATIENTS IN NEED THIS YEAR. IN FY2020, THE BTM TEAM DEMONSTRATED THEIR COMMITMENT TO PATIENTS BY COMPLETING A PROJECT THAT SIMPLIFIED THE APPLICATION PROCESS FOR TRANSPLANT CENTER COORDINATORS, PATIENTS AND THEIR FAMILIES. THESE IMPROVEMENTS TO THE APPLICATION REMOVE ANOTHER BARRIER FOR TRANSPLANT PATIENTS, BY REMOVING THE NEED FOR A PRE-APPROVAL FOR SEARCH ASSISTANCE FUNDS. (CONTINUED ON SCHEDULE O)TWO GRANT PROGRAMS SUPPORT PATIENTS PRE-TRANSPLANT WHO HAVE INSURANCE AND FINANCIAL BARRIERS THAT DELAY OR PREVENT THEM FROM FINDING A DONOR. THE FAMILY TYPING GRANT (FTG) PAYS LABS, ON BEHALF OF THE PATIENTS, FOR THE TYPING OF FIRST DEGREE RELATIVES NEEDED TO IDENTIFY IF THERE IS A DONOR IN THE FAMILY. THE FTG HELPED 79 PATIENTS THIS FY2020. FOR THOSE WITHOUT A DONOR IN THEIR FAMILY, SEARCH ASSISTANCE FUNDS (SAF) HELPS PATIENTS START THE UNRELATED DONOR SEARCH PROCESS BY GIVING TRANSPLANT CENTERS A GUARANTEE OF PAYMENT FOR SPECIFIC SEARCH AND/OR PROCUREMENT COSTS. THERE WERE 402 PATIENTS APPROVED FOR SAF THIS FY2020. BTMF ALSO PROVIDES FUNDING FOR TWO GRANTS TO HELP WITH THE MANY UNCOVERED EXTRA EXPENSES PATIENTS EXPERIENCE BEFORE AND AFTER A TRANSPLANT. THE TRANSPLANT SUPPORT ASSISTANCE (TSA) GRANT PROVIDES DIRECT FINANCIAL ASSISTANCE TO QUALIFIED FAMILIES BOTH PRE AND POST-TRANSPLANT. TSA HELPS WITH EXTRA OUT OF POCKET EXPENSES, SUCH AS TRANSPORTATION, TEMPORARY RELOCATION, CO-PAYS, AND INSURANCE PREMIUMS. THIS YEAR 1,435 TSA AWARDS WERE GRANTED WITH THE AVERAGE AWARD BEING $2,000 TO PATIENTS WHO WERE BOTH PRE AND POST-TRANPLANT.IN MAY 2020, BTMF OPENED A NEW, TEMPORARY GRANT TO MEET THE EVOLVING NEEDS OF PATIENTS DURING A GLOBAL PANDEMIC. THE COVID-19 RELIEF GRANT PROVIDES A ONE TIME $500 AWARD TO AID IN COVERING MEDICAL AND NON-MEDICAL EXPENSES DUE TO FINANCIAL HARDSHIP RELATED TO COVID. THIS YEAR 578 COVID AWARDS WERE GRANTED TO PATIENTS WHO WERE BOTH PRE AND POST-TRANSPLANT. THE JOHN AND CARYN CAMIOLO SURVIVORSHIP GRANT (CAM) PROVIDES DIRECT FINANCIAL ASSISTANCE TO QUALIFIED PATIENTS WHO ARE BEYOND ONE YEAR POST-TRANSPLANT AND WHO HAVE BEEN DIAGNOSED WITH CHRONIC GRAFT-VERSUS-HOST DISEASE. CAM HELPS WITH UNCOVERED COSTS OF TREATMENT AND PRESCRIPTIONS. THIS FY2020, 104 PATIENTS WERE HELPED THROUGH THE CAM PROGRAM WITH THE AVERAGE GRANT BEING $750.THE CHELL TRAVEL GRANT PROVIDES DIRECT FINANCIAL ASSISTANCE TO QUALIFIED PATIENTS WHO NEED ASSISTANCE WITH TRAVEL TO/FROM CLINICAL TRIALS THAT TREAT BLOOD CANCERS AND DISORDERS TREATABLE BY TRANSPLANT. THIS YEAR 104 CHELL TRAVEL GRANTS WERE AWARDED WITH THE AVERAGE AWARD AMOUNT BEING $2,000. THE IRA AND DIANA RIKLIS CRISIS GRANT PROVIDES DIRECT FINANICAL ASSISTANCE TO QUALIFIED PATIENTS POST-TRANSPLANT WHO HAVE EXPERIENCED A SIGNIFICANT CRISIS EVENT IMPACTING PATIENT'S POST TRANSPLANT CARE. THIS FY2020, 4 PATIENTS WERE HELPED THROUGH THE RIKLIS CRISIS PROGRAM WITH EACH AWARD AMOUNT BEING $10,000. 1246708 1246708 RESEARCH - RESEARCH INNOVATIONS ARE CRITICAL TO EXPANDING TREATMENT TO MORE PATIENTS AND IMPROVING OUTCOMES. EACH YEAR, BTMF IS PROUD TO INVEST IN RESEARCH THROUGH:THE AMY STRELZER MANASEVIT RESEARCH PROGRAM (AMY PROGRAM): OUR FLAGSHIP RESEARCH FELLOWSHIP, THE AMY PROGRAM FUNDS EARLY CAREER INVESTIGATORS FOCUSED ON ADVANCES IN THE PREVENTION AND TREATMENT OF POST-TRANSPLANT COMPLICATIONS (E.G. GRAFT-VERSUS-HOST-DISEASE AND INFECTION). IN FY2020, WE FUNDED THE WORK OF 18 AMY SCHOLARS. AMY SCHOLARS HAVE GONE ON TO BECOME LEADERS IN THE FIELD, PURSUING SCIENTIFIC ADVANCES THAT HELP BE THE MATCH PATIENTS LIVE LONGER, HEALTHIER LIVES. SINCE 1998, BTMF HAS INVESTED NEARLY $11 MILLION TO HELP (CONTINUED ON SCHEDULE O) LAUNCH THE CAREERS OF 44 YOUNG PHYSICIAN-SCIENTISTS. AFTER RECEIVING THEIR AMY SCHOLAR AWARDS, THIS GROUP HAS GONE ON TO WIN MORE THAN $110 MILLION IN SUBSEQUENT FUNDING TO PURSUE THE DISCOVERIES THAT WILL HELP PATIENTS LIVE LONGER, HEALTHIER LIVES AFTER TRANSPLANT. TODAY, THE AMY STRELZER MANASEVIT RESEARCH PROGRAM FOR THE STUDY OF POST-TRANSPLANT COMPLICATIONS IS ONE OF THE LARGEST AND MOST COVETED FELLOWSHIPS IN THE FIELD OF TRANSPLANTATION.ANTHONY NOLAN TRUST: PROVIDE SUPPORT TO THE ANTHONY NOLAN RESEARCH INSTITUTE TO CONTINUE DEVELOPMENT AND MAINTENANCE OF AN HLA CLASS I AND II SEQUENCE DATABASE AND PROVISION OF HLA CLASS I AND II SEQUENCE INFORMATION. 432850 432850 RECRUITMENT - THE BE THE MATCH REGISTRY PROVIDES THE MOST DIVERSE LISTING OF POTENTIAL DONORS AND CORD BLOOD UNITS IN THE WORLD. WITH 23 MILLION POTENTIAL DONORS AND 500,000 CORD BLOOD UNITS, OUR GROWING REGISTRY IS HELPING PATIENTS GET THE TRANSPLANT THEY NEED. IN FY2020, OVER 325,000 NEW POTENTIAL DONORS WERE ADDED TO THE BE THE MATCH REGISTRY. ALTHOUGH THERE ARE MILLIONS ON THE REGISTRY, PATIENTS SOMETIMES STILL CANNOT FIND A MATCH. THIS IS DUE IN PART TO THE PATIENT'S ETHNIC BACKGROUND. ON AVERAGE, A PATIENT'S LIKELIHOOD OF FINDING A MATCH ON THE BE THE MATCH REGISTRY RANGES FROM 29% TO 79% DEPENDING ON THE ETHNIC BACKGROUND. SOME ETHNIC GROUPS HAVE MORE COMPLEX TISSUE TYPES THAN OTHERS, SO A PERSON'S BEST CHANCE OF FINDING A DONOR IS WITH SOMEONE OF THE SAME ETHNIC (CONTINUED ON SCHEDULE O) BACKGROUND. THE IMPORTANCE OF INCREASING DIVERSITY ON THE REGISTRY IS AN ORGANIZATION GOAL AND PRIORITY AT BE THE MATCH.BE THE MATCH MEXICO WAS A NEW INITIATIVE IN 2017. WITH THE GOAL OF REACHING MORE PATIENTS AND INCREASING DIVERSITY ON THE REGISTRY, WORK HAS BEGUN TO CREATE A NETWORK OF DONOR CENTERS AND FUNDRAISING PARTNERS IN MEXICO. 4960175 1584868 BTMF PARTNERS WITH BE THE MATCH ON VARIOUS INITIATIVES TIED TO THE SHARED MISSION. THESE PROGRAMS INCLUDE:THE JASON CARTER CLINICAL TRIALS SEARCH AND SUPPORT PROGRAM HELPS PATIENTS WITH LIFE-THREATENING BLOOD DISORDERS FIND CLINICAL TRIALS. THIS PROGRAM USES A WEBSITE TO CONNECT PATIENTS AND THEIR FAMILIES WITH INFORMATION THAT THEY NEED TO FIND A CLINICAL TRIAL AND RECEIVE ONE-ON-ONE SUPPORT AND EDUCATION FROM A NMDP EDUCATION SPECIALIST. BE THE MATCH PROVIDES COMPREHENSIVE EDUCATION AND SUPPORT SERVICES TO PATIENTS AND THEIR FAMILIES THROUGH ONE-ON-ONE NAVIGATION SUPPORT, VIDEO, PRINTED, AND DIGITAL EDUCATION RESOURCES, COUNSELING, AND MORE. IN FY2020, BTMF HELPED TO FUND THE CREATION OF THE MYBETHEMATCH MOBILE APP, A PLATFORM TO HELP PATIENTS TRACK SYMPTOMS, MANAGE MEDICATIONS, AND ACCESS ADDITIONAL SUPPORT.BE THE MATCH IS A LEADER IN PROVIDING HEALTH CARE PROFESSIONALS WITH THE EDUCATION, RESOURCES AND SERVICES THEY NEED TO PROVIDE THE BEST CARE FOR TRANSPLANT PATIENTS. BTMF HELPS TO FUND THE CREATION AND DISTRIBUTION OF A NEWSLETTER FOCUSED ON THE ADVANCEMENTS IN TRANSPLANTATION AS WELL AS QUICK REFERENCE GUIDES, WITH AN ACCOMPANYING APP VERSION, THAT PROVIDES RESOURCES FOR HEALTH CARE PROFESSIONALS WHO CARE FOR PATIENTS BEFORE, DURING, AND/OR AFTER A TRANSPLANT.SPONSORSHIPS FOR THE BE THE MATCH ANNUAL ONE FORUM ARE RECEIVED BY BTMF AND THEN GIFTED TO BE THE MATCH. THIS MEETING CONNECTS ALL OF THE BTM NETWORK PARTNERS AND FOCUSES ON EDUCATION AND SHARING PROGRESS AND CHALLENGES RELATING TO TRANSPLANTS. BTMF ALLOCATES COMPENSATION AND BENEFITS AND OCCUPANCY COSTS TO PROGRAM BASED ON EMPLOYEE RESPONSIBILITIES. 4960175 1584868 11452758 1 1 0 0 0 0 0 0 0 1 1 0 0 0 0 1 0 1 0 0 1 1 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 192 0 1 41 1 0 1 MX 0 0 0 1 1 0 0 0 0 0 0 X 18 17 1 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AR CA FL GA HI IL KS KY MD MA MI MN MS NH NJ NM NY NC OR PA RI SC TN UT VA WV WI X X GINA GRAVES 7634068419 500 N 5TH ST MINNEAPOLIS MN 554011206 X C RANDAL MILLS CHIEF EXECUTIVE OFFICER-THRU 2/2020 2.00 48.00 X X 0 1181899 58331 AMY RONNEBERG CFO-THRU 2/2020; CEO-AS OF 2/2020 1.00 49.00 X X 0 790190 32792 JOY KING EXEC. DIR. BTMF/SVP PHILAN. 20.00 30.00 X 152539 228809 59546 GINA GRAVES ACTING CFO - AS OF 3/2020 1.00 49.00 X 0 266669 15209 STEPHEN STOUT SR. DIR., MAJOR GIFTS-THRU 9/2020 50.00 0.00 X 198091 0 43518 JACQUELINE CHANDONNET DIRECTOR, DEVELOPMENT 50.00 0.00 X 159856 0 20322 MARY BETH HEFFERNAN SR DIR PUBLIC ENGAGE/OPS-THRU 8/2019 50.00 0.00 X 156065 0 19778 KRISTIN SCOTT DIRECTOR, DEVELOPMENT 50.00 0.00 X 133399 0 15116 DANIEL LEE MANAGER, ADO & MAJOR GIFTS DIR. 50.00 0.00 X 121523 0 17036 JOSEPH LOUGHRAN CHAIR-THRU 1/2020; DIRECTOR 1.00 0.00 X 0 0 0 ANNE MCGEORGE V.C.-THRU 2/2020; CHAIR-AS OF 1/2020 1.00 0.00 X 0 0 0 ROGER PASCHKE SECRETARY 1.00 0.00 X 0 0 0 DIANA CARTER TREASURER 1.00 0.00 X 0 0 0 JASON AHLGREN DIRECTOR 1.00 0.00 X 0 0 0 GUSTAVO ALCOCER DIRECTOR 1.00 0.00 X 0 0 0 ANNIE BALLANTINE DIRECTOR 1.00 0.00 X 0 0 0 ANDREW BLOCK DIRECTOR 1.00 0.00 X 0 0 0 BRUCE MANASEVIT DIRECTOR 1.00 0.00 X 0 0 0 NICOLE MOORE DIRECTOR 1.00 0.00 X 0 0 0 DAVID PEARCE DIRECTOR 1.00 0.00 X 0 0 0 DERYN POMEROY DIRECTOR 1.00 0.00 X 0 0 0 RICHARD RIEGER DIRECTOR 1.00 0.00 X 0 0 0 MICHAEL ROSE DIRECTOR 1.00 0.00 X 0 0 0 RENE SIGMAN DIRECTOR 1.00 0.00 X 0 0 0 MICHAEL STEWART DIRECTOR 1.00 0.00 X 0 0 0 THOMAS TEACH DIRECTOR 1.00 0.00 X 0 0 0 921473 2467567 281648 11 0 1 0 ONE & ALL INC 2 NORTH LAKE AVENUE SUITE 600 PASADENA CA 91101 PROGRAM SUPPORT 643336 LEARFIELD COMMUNICATIONS 505 HOBBS ROAD JEFFERSON CITY MO 65109 ADVERTISING 551250 COMMUNITY COUNSELING SERVICE 527 MADISON AVENUE FIFTH FLOOR NEW YORK NY 10022 PROGRAM SUPPORT 518625 BLACKBAUD PO BOX 930256 ATLANTA GA 31193 SOFTWARE SUPPORT 139916 CIPRIANI USA INC 25 BROADWAY BALLROOM 110 EAST 42ND NEW YORK NY 10017 FUNDRAISING EVENT SPACE 116061 5 1232520 8521000 8281130 303432 18034650 238703 238703 1686869 1450878 235991 235991 235991 99420 1232520 330014 -230594 -230594 2900 7262 -4362 -4362 18274388 0 0 239738 3098982 3098982 4510469 4510469 468000 468000 178656 126846 25012 26798 2983481 2118272 417687 447522 132407 94009 18537 19861 280442 199113 39261 42068 243943 173200 34152 36591 29122 29122 615139 615139 6037 6037 207988 164310 37438 6240 88456 88456 151329 57505 4540 89284 28889 22822 5200 867 150835 107093 21117 22625 251893 219147 32746 14003 14003 REGISTRATION/MEMBERSHIP 15642 15642 RECOGNITION 11934 4534 358 7042 UBI TAX EXPENSE -3000 -3000 13464647 11452758 697852 1314037 0 0 2764568 2835023 3929877 3482711 0 0 0 0 0 0 0 0 0 0 328144 401320 6823 6823 0 0 9225862 10501506 0 0 0 0 0 0 0 0 16248451 17220560 8119745 4327057 1569710 1206579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9689455 5533636 X -3228655 3809037 9787651 7877887 6558996 11686924 16248451 17220560 4809741 318187 0 X 0 1 X 1 0 X 8943953 11148511 11051487 10751245 18034650 59929846 8943953 11148511 11051487 10751245 18034650 59929846 16358826 43571020 265875 274817 229695 247043 238703 1256133 318593 552210 345444 198404 102320 1516971 62702950 0.69490 0.73100 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: FUNDRAISING REVENUE - 2015 AMOUNT: $ 302,993. 2016 AMOUNT: $ 532,510. 2017 AMOUNT: $ 324,124. 2018 AMOUNT: $ 176,304. 2019 AMOUNT: $ 99,420. GAMING REVENUE - 2015 AMOUNT: $ 15,600. 2016 AMOUNT: $ 19,700. 2017 AMOUNT: $ 21,320. 2018 AMOUNT: $ 22,100. 2019 AMOUNT: $ 2,900. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 4612433 200500 285815 5098748 1407960 2963973 240500 4612433 1407960 1407960 0.63540 0.36460 0 0 0 0 1828 1828 0 4995 4995 0 0 X PART V, LINE 4: INTENDED USES OF ENDOWMENT FUNDS THE INTENDED USES OF THE ENDOWMENT FUNDS ARE TO SUPPORT RESEARCH AND PATIENT ASSISTANCE. PART X, LINE 2: ORGANIZATION'S LIABILITY FOR UNCERTAIN TAX POSITIONS UNDER ASC 740 THE INTERNAL REVENUE SERVICE HAS DETERMINED THAT THE PROGRAM AND BTMF ARE TAX-EXEMPT ORGANIZATIONS UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THE NOT-FOR-PROFIT STATUS OF THE PROGRAM AND BTMF ARE CONSIDERED TAX POSITIONS UNDER FASB ASC 740, INCOME TAXES. THE ORGANIZATION FOLLOWS THE ACCOUNTING STANDARDS FOR CONTINGENCIES IN EVALUATING UNCERTAIN TAX POSITIONS. THIS GUIDANCE PRESCRIBES RECOGNITION THRESHOLD PRINCIPLES FOR THE FINANCIAL STATEMENT RECOGNITION OF TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN ON A TAX RETURN THAT ARE NOT CERTAIN TO BE REALIZED. NO LIABILITY HAS BEEN RECOGNIZED BY THE ORGANIZATION FOR UNCERTAIN TAX POSITIONS AS OF SEPTEMBER 30, 2020 OR 2019. THE ORGANIZATION'S TAX RETURNS ARE SUBJECT TO REVIEW AND EXAMINATION BY FEDERAL AND STATE AUTHORITIES. 1 NORTH AMERICA 1 0 GRANTMAKING 400000 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTMAKING 68000 1 0 0 0 1 0 468000 0 468000 NORTH AMERICA MEXICO RECRUITMENT 400000 WIRE EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH/SCHOLAR 68000 CHECK/WIRE 2 0 0 1 0 0 0 PART I, LINE 2: PROCEDURES FOR MONITORING THE USE OF GRANTS OUTSIDE THE U.S. THE GRANTS PROVIDED TO MEXICO ARE TO BE THE MATCH MEXICO A.C., WHICH IS A RELATED ORGANIZATION. THESE FUNDS ARE USED FOR FUNDRAISING AND RECRUITMENT OF MEXICO DONORS TO THE BE THE MATCH REGISTRY AND ARE MONITORED THROUGH REGULAR FINANCIAL UPDATES AND OVERSIGHT OF THE BE THE MATCH MEXICO A.C. BOARD OF DIRECTORS. THE GRANT PROVIDED TO ITALY IS PART OF A BONE MARROW TRANSPLANT RESAERCH SCHOLAR PROGRAM THAT WAS STARTED MANY YEARS AGO. THE GRANTEES ARE REQUIRED ON A BI-ANNUAL BASIS TO SUBMIT DETAILED PROGRESS REPORTS TO BE THE MATCH THAT OUTLINE THE USE OF FUNDS. THE PAYMENTS ARE MADE TO THE INSTITUTION THAT THE SCHOLAR IS CONDUCTING RESEARCH AS AN ADDITIONAL PRECAUTION THAT THE FUNDS ARE USED FOR THEIR INTENDED PURPOSE. PART III ACCOUNTING METHOD: X X X X X X 1 COMMUNITY COUNSELING SERVICE 527 MADISON AVE 5TH FL NEW YORK NY 10022 FUNDRAISING CONSULTANT 0 0 415695 0 ONE & ALL INC 2 NORTH LAKE AVE STE 600 PASADENA CA 911011868 FUNDRAISING CONSULTANT 0 0 199444 0 615139 AL AK AR CA CO CT FL GA HI IL KS KY ME MD MA MI MN MO MS NV NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI VIRTUAL GALA 622833 572632 50201 130003 11097 ST LOUIS SOIREE 622685 620914 1771 20159 39774 8864 12543 2 86422 38974 47448 22500 11581 62798 10695 1331940 1232520 99420 42659 51355 201665 34335 330014 -230594 SCHEDULE G, PART I, LINE 2B, COLUMN (IV) GROSS RECEIPTS FROM FUNDRAISERS THE GROSS RECEIPTS FROM THE ACTIVITIES THAT ONE & ALL INC AND COMMUNITY COUNSELING SERVICE ASSIST OUR ORGANIZATION ON ARE NOT ABLE TO BE SEPARATELY REPORTED. ONE & ALL INC WORKS ON OUR DIRECT MAIL AND ONLINE GIVING APPEALS. COMMUNITY COUNSELING SERVICE WORKS ON GENERAL FUNDRAISING STRATEGY AND FUNDRAISING CAMPAIGN CONSULTING. THE WORK OF THESE ORGANIZATION AIDS IN MANY OF OUR FUNDRAISING INITIATIVES THROUGHOUT OUR FISCAL YEAR AND THUS CANNOT BE SEPARATELY REPORTED. 1 NATIONAL MARROW DONOR PROGRAM 500 N 5TH STREET MINNEAPOLIS MN 55401 840865803 501(C)(3) 692364 VARIOUS NMDP PROGRAM NATIONAL MARROW DONOR PROGRAM 500 N 5TH STREET MINNEAPOLIS MN 55401 840865803 501(C)(3) 462559 BTMM PATIENT ASSISTANCE NATIONAL MARROW DONOR PROGRAM 500 N 5TH STREET MINNEAPOLIS MN 55401 840865803 501(C)(3) 316083 CLINICAL TRIALS SUPPORT NATIONAL MARROW DONOR PROGRAM 500 N 5TH STREET MINNEAPOLIS MN 55401 840865803 501(C)(3) 254708 RESEARCH WASHINGTON UNIVERSITY OF ST LOUIS 600 SOUTH EUCLID AVENUE ST LOUIS MO 63110 430654872 501(C)(3) 150000 RESEARCH/SCHOLAR NATIONAL MARROW DONOR PROGRAM 500 N 5TH STREET MINNEAPOLIS MN 55401 840865803 501(C)(3) 148434 BTMBT FRED HUTCHINSON CANCER RESEARCH CENTER MAILSTOP LF-272 PO BOX 19024 SEATTLE WA 98109 237156071 501(C)(3) 108000 RESEARCH/SCHOLAR UNIVERSITY OF ALABAMA 701 20TH STREET SOUTH BIRMINGHAM AL 35294 630649108 501(C)(3) 80000 RESEARCH/SCHOLAR DANA-FABER CANCER INSTITUTE PO BOX 414744 BOSTON MA 02241 042263040 501(C)(3) 80000 RESEARCH/SCHOLAR UNIVERSITY NORTH CAROLINA AT CHAPEL HILL PO BOX 402420 ATLANTA GA 30384 566001393 501(C)(3) 80000 RESEARCH/SCHOLAR MEMORIAL SLOAN KETTERING CANCER CENTER 633 3RD AVENUE 4TH FLOOR NEW YORK NY 10017 131924236 501(C)(3) 74000 RESEARCH/SCHOLAR UNIVERSITY OF CALIFORNIA SAN FRANCISCO UCSF MAIN DEPOSITORY PO BOX 748872 LOS ANGELES CA 90074 946036493 501(C)(3) 70000 RESEARCH/SCHOLAR BAYLOR SCHOOL OF MEDICINE IN HOUSTON PO BOX 4803 HOUSTON TX 77210 741613878 501(C)(3) 68000 RESEARCH/SCHOLAR UNIVERSITY OF PITTSBURGH PO BOX 371220 PITTSBURGH PA 15251 250965591 501(C)(3) 68000 RESEARCH/SCHOLAR CHILDRENS HOSPITAL CORPORATION 300 LONGWOOD AVENUE BOSTON MA 02115 042774441 501(C)(3) 40000 RESEARCH/SCHOLAR UNIVERISTY OF MINNESOTA 2221 UNIVERSITY AVENUE S SUITE 111 MINNEAPOLIS MN 55414 416042488 501(C)(3) 36000 RESEARCH/SCHOLAR UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE BOULEVARD HOUSTON TX 77030 746001118 501(C)(3) 36000 RESEARCH/SCHOLAR CHILDREN'S RESEARCH INSTITUTE 801 ROEDER ROAD SUITE 500 SILVER SPRING MD 20910 521654453 501(C)(3) 34000 RESEARCH/SCHOLAR HISTOGENETICS 300 EXECUTIVE BOULEVARD OSSINING NY 10562 205412180 20350 DONOR RECRUITMENT NATIONAL MARROW DONOR PROGRAM 500 N 5TH STREET MINNEAPOLIS MN 55401 840865803 501(C)(3) 12500 DONOR RECRUITMENT NATIONAL MARROW DONOR PROGRAM 500 N 5TH STREET MINNEAPOLIS MN 55401 840865803 501(C)(3) 267984 BOOK SALARY PROGRAM SUPPORT 14 1 COVID PATIENT ASSISTANCE 578 289000 PATIENT TRANSPLANT ASSISTANCE 1438 2982750 CLINICAL TRIALS ASSISTANCE 104 206450 PATIENT TYPING & SEARCH ASSISTANCE 79 872266 DONOR ASSISTANCE 236 160003 PART I, LINE 2: PROCEDURE FOR MONITORING THE USE OF GRANT FUNDS INSIDE THE U.S. PATIENT ASSISTANCE GRANTS ARE AWARDED THROUGH BTMF. PATIENTS APPLY FOR PRE- AND POST-TRANSPLANT SUPPORT GRANTS THROUGH THE ONLINE APPLICATION. THESE APPLICATIONS AND PATIENT ASSISTANCE ARE TRACKED IN OUR CUSTOM-BUILT SYSTEM AND MONITORED BY THE PATIENT OUTCOMES AND EXPERIENCES TEAM, A DEPARTMENT WITHIN NATIONAL MARROW DONOR PROGRAM (NMDP). THIS TEAM REVIEWS APPLICATIONS WEEKLY AND DETERMINES ASSISTANCE NEEDS BASED ON PUBLISHED CRITERIA, ALL WITH THE GOAL TO EQUITABLY ADMINISTER TO HELP PATIENTS OVERCOME BARRIERS BEFORE AND AFTER TRANSPLANT. SEARCH ASSISTANCE FUNDS ARE AWARDED TO COVER POTENTIALLY UNINSURED DONOR SEARCH COSTS AND ARE DISTRIBUTED DIRECTLY TO TRANSPLANT CENTERS (ORGANIZATIONS). ALL OTHER PATIENT ASSISTANCE GRANTS ARE AWARDED TO THE APPLICANT BASED ON FINANCIAL NEED AND ARE USED TO COVER SUCH ITEMS AS UNINSURED COSTS, CO-PAYS, FOOD, LODGING, AND GROUND TRANSPORTATION. PAYMENTS ARE MADE DIRECTLY TO THE PATIENT/APPLICANT (INDIVIDUAL). DONOR ASSISTANCE CHECKS ARE ALSO AWARDED TO THE APPLICANT BASED ON FINANCIAL NEEDS AND ARE USED TO OFFSET HAVING TO TAKE UNPAID TIME OFF FROM WORK IN ORDER TO DONATE LIFE-SAVING CELLS. PAYMENTS ARE MADE DIRECTLY TO THE DONOR (INDIVIDUAL). SCHEDULE I, PART II, LINE 1(H): PURPOSE OF GRANT DONOR RECRUITMENT REFERS TO ADDING NEW DONORS TO THE BE THE MATCH REGISTRY. SCHEDULE I, PART III: GRANTS AND OTHER ASSISTANCE TO DOMESTIC INDIVIDUALS COVID PATIENT ASSISTANCE IS A NEW TEMPORARY ASSISTANCE TO HELP ENSURE PATIENTS CAN MAINTAIN THEIR ACCESS TO LIFE-SAVING TREATMENTS DURING THIS UNPRECEDENTED TIME. THIS ASSISTANCE PROVIDES A ONE-TME $500 FINANCIAL RELIEF GRANT TO HELP PATIENTS WITH MEDICAL AND NON-MEDICAL EXPENSES. PATIENT TRANSPLANT ASSISTANCE HAS BEEN EXPANDED TO NOT ONLY HELP PATIENTS OVERCOME BARRIERS AFTER TRANSPLANT, BUT NOW BEFORE TRANSPLANT AS WELL. CLINICAL TRIALS ASSISTANCE WAS FORMERLY CALLED TRAVEL ASSISTANCE. THIS ASSISTANCE IS SPECIFICALLY DESIGNED TO HELP PATIENTS WHO ARE ENROLLED OR IN THE PROCESS OF ENROLLING IN A CLINICAL TRIAL FOR A BLOOD CANCER OR BLOOD DISORDER AND NEED ASSISTANCE COVERING TRAVEL EXPENSES. PATIENT TYPING AND SEARCH ASSISTANCE WERE FORMALLY REPORTED SEPARATELY AND CALLED FAMILY TYPING GRANT AND PATIENT SEARCH ASSISTANCE GRANTS. BOTH OF THESE FORMS OF ASSISTANCE HELP PATIENTS IN THE PRE-TRANSPLANT PHASE OVERCOME BARRIERS RELATED TO INADEQUATE HEALTH INSURANCE COVERAGE RELATED TO HLA TYPING OF FIRST-DEGREE RELATIVE(S) AND OR AN UNRELATED DONOR SEARCH. 1 1 0 0 0 0 0 1 0 C RANDAL MILLS CHIEF EXECUTIVE OFFICER-THRU 2/2020 0 701815 0 352046 0 128038 0 24856 0 33475 0 1240230 0 0 AMY RONNEBERG CFO-THRU 2/2020; CEO-AS OF 2/2020 0 499509 0 222429 0 68252 0 24856 0 7936 0 822982 0 0 JOY KING EXEC. DIR. BTMF/SVP PHILAN. 102529 153794 36831 55247 13179 19768 9942 14914 13876 20814 176357 264537 0 0 GINA GRAVES ACTING CFO - AS OF 3/2020 0 192155 0 57382 0 17132 0 0 0 15209 0 281878 0 0 STEPHEN STOUT SR. DIR., MAJOR GIFTS-THRU 9/2020 159726 0 36514 0 1851 0 13737 0 29781 0 241609 0 0 0 JACQUELINE CHANDONNET DIRECTOR, DEVELOPMENT 141595 0 16975 0 1286 0 10667 0 9655 0 180178 0 0 0 MARY BETH HEFFERNAN SR DIR PUBLIC ENGAGE/OPS-THRU 8/2019 94211 0 0 0 61854 0 0 0 19778 0 175843 0 0 0 PART I, LINE 3 TOP MANAGEMENT'S COMPENSATION BTMF USES NMDP'S COMPENSATION COMMITTEE WHICH IS CHARGED WITH SETTING THE COMPENSATION OF NMDP'S CEO. AS REPORTED ON NMDP'S FORM 990, SCHEDULE J, A COMPENSATION COMMITTEE, INDEPENDENT COMPENSATION CONSULTANT, WRITTEN EMPLOYMENT CONTRACT, COMPENSATION SURVEY OR STUDY, AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE ARE ALL UTILIZED WHEN DETERMINING COMPENSATION. THE NMDP BYLAWS STATE: "THE COMPENSATION COMMITTEE SHALL BE COMPRISED ONLY OF VOTING DIRECTORS AND SHALL INCLUDE THE CHAIR OF THE BOARD AND AT LEAST ONE (1) NOT-OFFICER BOARD MEMBER AS VOTING COMMITTEE MEMBERS. THE COMPENSATION COMMITTEE SHALL REVIEW AND EVALUATE THE OVERALL COMPENSATION AND BENEFIT STRUCTURE OF THE CORPORATION AND SHALL HAVE SUCH OTHER AUTHORITY AND RESPONSIBILITIES AS SET FORTH IN THE COMPENSATION COMMITTEE CHARTER." THE COMPENSATION COMMITTEE CHARTER STATES: "THE COMMITTEE SHALL REVIEW AND EVALUATE THE OVERALL COMPENSATION AND BENEFIT STRUCTURE OF THE CORPORATION, AND APPROVE AND ADOPT A COMPENSATION PHILOSOPHY AND PRINCIPLES CONSISTENT WITH THE CORPORATION'S NOT-FOR-PROFIT STATUS (THE COMPENSATION PHILOSOPHY AND PRINCIPLES). THE COMMITTEE SHALL CONDUCT THE CHIEF EXECUTIVE OFFICER (CEO) PERFORMANCE EVALUATION. THE COMMITTEE SHALL MAKE CEO TOTAL COMPENSATION AND BENEFIT RECOMMENDATIONS TO THE EXECUTIVE COMMITTEE, CONSISTENT WITH THE COMPENSATION PHILOSOPHY AND PRINCIPLES. IN MAKING COMPENSATION AND BENEFIT RECOMMENDATIONS FOR THE CEO, THE COMMITTEE SHALL UTILIZE, AMONG OTHER THINGS, COMPARABILITY DATA FOR COMPLIANCE WITH IRS INTERMEDIATE SANCTION PROVISIONS SO AS TO ALLOW THE CORPORATION TO TAKE ADVANTAGE OF THE REBUTTABLE PRESUMPTION OF REASONABLENESS. ON A PERIODIC BASIS, THE COMMITTEE SHALL OBTAIN COMPARABILITY DATA FROM AN INDEPENDENT COMPENSATION CONSULTANT. IN ADDITION, THE COMMITTEE SHALL ADVISE THE CEO IN HIS/HER/THEIR EVALUATION OF AND DECISIONS REGARDING THE COMPENSATION OF AND BENEFITS FOR SENIOR CORPORATION EMPLOYEES, AS WELL AS THE PRESIDENT (OR EQUIVALENT LEADER) OF ANY SUBSIDIARY OF THE CORPORATION REPORTING TO THE CEO (TOGETHER, SENIOR LEADERSHIP). IN ADVISING THE CEO IN MAKING HIS/HER/THEIR COMPENSATION AND BENEFIT DECISIONS FOR SENIOR LEADERSHIP, THE COMMITTEE SHALL ENSURE THAT SUCH DECISIONS ARE CONSISTENT WITH THE COMPENSATION PHILOSOPHY AND PRINCIPLES, AND UTILIZE, AMONG OTHER THINGS, COMPARABILITY DATA FOR COMPLIANCE WITH IRS INTERMEDIATE SANCTION PROVISIONS. IF DECISIONS PROPOSED BY THE CEO ARE OUTSIDE THE PARAMETERS OF THE COMPENSATION PHILOSOPHY AND PRINCIPLES, THE CEO MUST OBTAIN THE COMMITTEE'S APPROVAL PRIOR TO IMPLEMENTATION." PART I, LINES 4A-B LINE 4A SEVERANCE PAYMENT THE FOLLOWING INDIVIDUAL LEFT BTMF DURING 2019 AND RECEIVED A SEPARATION PAYMENT DURING CALENDAR YEAR 2019. THE AMOUNT HAS BEEN INCLUDED IN SCHEDULE J, PART II, COLUMN B (III): MARY BETH HEFFERNAN $52,908.84 LINE 4B SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN THE ORGANIZATION OFFERS ITS OFFICERS, SENIOR VICE PRESIDENTS, VICE PRESIDENTS, AND DIRECTORS A 457(B) DEFERRED COMPENSATION PLAN (THE "PLAN") CREATED IN ACCORDANCE WITH APPLICABLE PROVISIONS OF THE INTERNAL REVENUE CODE. THE PLAN PERMITS EMPLOYEES TO DEFER A PORTION OF THEIR SALARY UNTIL FUTURE YEARS. THE ACCUMULATED DEFERRED COMPENSATION BALANCE IS NOT AVAILABLE TO EMPLOYEES UNTIL TERMINATION, RETIREMENT, DEATH, OR UNFORESEEABLE EMERGENCY. ALL AMOUNTS OF COMPENSATION DEFERRED UNDER THE PLAN, AND ALL INCOME ATTRIBUTABLE TO THOSE AMOUNTS, ARE (UNTIL PAID OR MADE AVAILABLE TO THE EMPLOYEE OR OTHER BENEFICIARY) SOLELY THE PROPERTY OF THE ORGANIZATION, AND THE ORGANIZATION HAS ALL THE RELATED RIGHTS OF OWNERSHIP (NOT RESTRICTED TO THE PAYMENT OF BENEFITS UNDER THE PLAN), SUBJECT ONLY TO THE CLAIM OF THE ORGANIZATION'S GENERAL CREDITORS. PARTICIPANTS' RIGHTS UNDER THE PLAN ARE EQUAL TO THOSE OF GENERAL CREDITORS OF THE ORGANIZATION IN AN AMOUNT EQUAL TO THE FAIR MARKET VALUE OF THE DEFERRED ACCOUNT FOR EACH PARTICIPANT. THE RELATED ASSETS AND LIABILITIES ARE REPORTED AT FAIR MARKET VALUE BASED ON QUOTED MARKET PRICES AND ARE INCLUDED WITHIN DEFERRED COMPENSATION FUNDS AND DEFERRED COMPENSATION PAYABLE IN THE CONSOLIDATED STATEMENTS OF FINANCIAL POSITION. THE ORGANIZATION OFFERS A SUPPLEMENTAL BENEFITS PLAN (THE "SUPPLEMENTAL PLAN") FOR ITS OFFICERS, SENIOR VICE PRESIDENTS, AND VICE PRESIDENTS. EACH YEAR, THE SUPPLEMENTAL PLAN CONTRIBUTES 14% OF SALARY FOR THE CHIEF EXECUTIVE OFFICER, 12% FOR THE CHIEF FINANCIAL OFFICER, 9% FOR OTHER OFFICERS AND SENIOR VICE PRESIDENTS, AND 4% FOR VICE PRESIDENTS. THE SUPPLEMENTAL PLAN IS A FLEXIBLE BENEFIT PLAN ALLOWING THE SUPPLEMENTAL PLAN PARTICIPANTS TO SELECT FROM LIMITED OPTIONS, WHICH INCLUDE PAYMENT FOR SPOUSAL LONG-TERM CARE, AND THE BALANCE AS A CONTRIBUTION INTO THE 457(B) DEFERRED COMPENSATION PLAN (ABOVE) AND/OR AN EXECUTIVE SAVINGS PLAN TO SUPPLEMENT CURRENT BASIC AND SUPPLEMENTAL BENEFITS. THE EXECUTIVE SAVINGS PLAN REPLACED THE CAPITAL ACCUMULATION PLAN EFFECTIVE JANUARY 1, 2013. ALL SUPPLEMENTAL PLAN PARTICIPANTS RECEIVE LIFE INSURANCE, DISABILITY SALARY CONTINUATION, LONG-TERM DISABILITY AND LONG-TERM CARE INSURANCE. THE EXECUTIVE SAVINGS PLAN WAS CREATED IN ACCORDANCE WITH APPLICABLE PROVISIONS OF THE INTERNAL REVENUE CODE (IRC SEC 7702) WHEREBY AFTER-TAX CONTRIBUTIONS INTO THE PLAN ACCUMULATE WITHOUT TAXATION AND MAY BE DISTRIBUTED WITHOUT TAXATION USING A COMBINATION OF TAX-FREE WITHDRAWALS AND LOANS. CONTRIBUTIONS WILL RESULT IN CURRENT INCOME TAXATION. PLAN BALANCES ARE PERSONALLY OWNED BY THE PLAN PARTICIPANTS IMMEDIATELY AND ARE NOT SUBJECT TO A RISK OF FORFEITURE; AS SUCH, THE PLAN ASSETS ARE NOT RECORDED ON THE ORGANIZATION'S FINANCIAL STATEMENTS. THE SUPPLEMENTAL PLAN ALSO PROVIDES FOR ADDITIONAL LIFE INSURANCE UP TO $750,000. PART I, LINE 7 NON-FIXED PAYMENTS EMPLOYEE INCENTIVE PLAN PAYMENTS ARE DETERMINED EACH YEAR AS PART OF THE PERFORMANCE EVALUATION COMPLETED BY HUMAN RESOURCES IN COLLABORATION WITH THE INDIVIDUAL'S MANAGER. THE ANNUAL INCENTIVE PLAN IS DETERMINED BY TAKING INTO ACCOUNT THE RESULTS OF THE ORGANIZATION'S OPERATING METRICS AND EACH DEPARTMENT'S GOALS. X 11 110358 FMV X AUCTION ITEMS 139 193074 FMV 0 1 0 FORM 990, PART I, LINE 6 TOTAL NUMBER OF VOLUNTEERS THE NUMBER OF VOLUNTEERS DECREASED COMPARED TO TAX YEAR ENDED SEPTEMBER 30, 2019 PRIMARILY DUE TO A DECREASE IN VOLUNTEER OPPORTUNITIES, OTHER THAN BONE MARROW COURIER, AND CHANGES IN MANY BE THE MATCH OPERATIONS LIKE NO IN PERSON DONOR RECRUITMENT DRIVES AND FUNDRAISING EVENTS DURING THE COVID-19 PANDEMIC. CONTINUATION OF ORGANIZATION'S MISSION: CONNECTS PATIENTS WITH A MATCHING DONOR FOR A LIFE-SAVING BLOOD STEM CELL TRANSPLANT. THE BE THE MATCH REGISTRY IS THE MOST DIVERSE REGISTRY IN THE WORLD AND INCLUDES BOTH ADULT DONORS WILLING TO DONATE TO A STRANGER IN NEED AND STORED CORD BLOOD UNITS. IN ADDITION, BE THE MATCH PROVIDES PATIENTS AND THEIR FAMILIES ONE-ON-ONE SUPPORT, EDUCATION, AND GUIDANCE BEFORE, DURING AND AFTER TRANSPLANT. BE THE MATCH IS ALSO A GLOBAL LEADER IN RESEARCH THROUGH THE CIBMTR (CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH), A COLLABORATION WITH MEDICAL COLLEGE OF WISCONSIN, INVESTING IN AND MANAGING RESEARCH STUDIES THAT IMPROVE PATIENT OUTCOMES AND ADVANCE THE FUTURE OF CARE. THE BE THE MATCH FOUNDATION RAISES FUNDS TO HELP PATIENTS BY: - ADDING NEW POTENTIAL DONORS TO THE REGISTRY - HELPING PAY UNINSURED PATIENT COSTS ASSOCIATED WITH TRANSPLANT - FUNDING LIFE-SAVING RESEARCH THROUGH THE CIBMTR. WITH THE SUPPORT OF OUR CONTRIBUTORS, EACH YEAR, WE: - FACILITATE MORE MARROW AND CORD BLOOD TRANSPLANTS - GROW AND DIVERSIFY THE WORLD'S LARGEST AND MOST DIVERSE DONOR REGISTRY - SUPPORT PATIENTS AND THEIR FAMILIES BEFORE, DURING AND AFTER TRANSPLANT - CONDUCT RESEARCH AND EDUCATION TO EXPAND TREATMENT AND IMPROVE OUTCOMES - ENGAGE THE PUBLIC IN OUR LIFE-SAVING MISSION. AS THE WORLD'S LEADING NONPROFIT ORGANIZATION FOCUSED ON SAVING LIVES THROUGH CELLULAR THERAPY, BE THE MATCH CONTINUES TO IMPROVE ACCESS TO TRANSPLANT BY LEADING EFFORTS TO REMOVE BARRIERS TO TREATMENT AND STRENGTHEN OUR ABILITY TO MEET THE GROWING NEED. THANKS TO OUR COMMUNITY OF DONORS, VOLUNTEERS, HEALTH CARE PROFESSIONALS, RESEARCHERS AND FINANCIAL SUPPORTERS, MORE PATIENTS EVERY YEAR ARE RECEIVING THE LIFE-SAVING MARROW OR CORD BLOOD TRANSPLANT THEY NEED. ON BEHALF OF ALL THE PEOPLE WHO COUNT ON US WHEN THEY NEED IT MOST, WE THANK OUR CONTRIBUTORS FOR THEIR NEVER-ENDING PASSION AND DEDICATION TO SAVING LIVES. FORM 990, PART VI, SECTION A, LINE 2 REPORTABLE RELATIONSHIPS THE FOLLOWING DIRECTORS OF BTMF HAVE A REPORTABLE BUSINESS RELATIONSHIP: ANNE MCGEORGE AND AMY RONNEBERG (MS. MCGEORGE AND MS. RONNEBERG WERE BOTH VOTING DIRECTORS OF MAGENTA THERAPEUTICS DURING FY2020) FORM 990, PART VI, SECTION A, LINE 6 MEMBERS OR STOCKHOLDERS NMDP IS THE SOLE CORPORATE MEMBER OF BTMF. FORM 990, PART VI, SECTION A, LINE 7A MEMBERS OR STOCKHOLDERS WHO MAY ELECT GOVERNING BODY THE NMDP BOARD ELECTS THE BOARD OF DIRECTORS OF BTMF. FORM 990, PART VI, SECTION A, LINE 7B MEMBERS OR STOCKHOLDERS WHO MAY APPROVE DECISIONS THE NMDP BOARD APPROVES THE ACTIONS OF BTMF. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 REVIEW PROCESS THE ORGANIZATION CONTRACTED WITH THE OUTSIDE PUBLIC ACCOUNTING FIRM, GRANT THORNTON LLP, TO PREPARE THE FORM 990. PREPARING THE DETAILS AND SUPPORTING REPORTS FOR THE RETURN IS A COLLABORATIVE EFFORT AMONG A SMALL GROUP OF INDIVIDUALS IN THE FINANCIAL REPORTING & COMPLIANCE AREA OF FINANCE, INTERNAL AUDIT AND HUMAN RESOURCES. THAT WORK IS THEN REVIEWED BY THE SENIOR MANAGER OF FINANCIAL REPORTING PRIOR TO SENDING TO GRANT THORNTON LLP; THE CHIEF LEGAL OFFICER ALSO REVIEWS THE GOVERNANCE SECTIONS PRIOR TO SENDING TO GRANT THORNTON LLP. ONCE A DRAFT IS RECEIVED BACK FROM GRANT THORNTON LLP, IT IS REVIEWED BY THE TEAM THAT PULLED THE DETAILS TOGETHER, NMDP ACTING CHIEF FINANCIAL OFFICER AND EXECUTIVE DIRECTOR OF BTMF. A COPY OF THE RETURN IS PROVIDED TO THE NMDP AUDIT AND FINANCE COMMITTEE AND BTMF BOARD OF DIRECTORS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST POLICY MONITORING & ENFORCEMENT THE CONFLICT OF INTEREST POLICY STATES THE FOLLOWING: "THE EXISTENCE OF AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST TURNS ON THE SPECIFIC FACTS AND CIRCUMSTANCES IN EACH CASE. IF A MEMBER HAS AN INTEREST WHICH MAY CONFLICT WITH THOSE OF THE ORGANIZATIONS, HE/SHE/THEY MUST IMMEDIATELY DISCLOSE THE MATTERS AND DISCUSS THEM FULLY AND FRANKLY WITH THE APPLICABLE ORGANIZATION'S FULL BOARD OR ITS EXECUTIVE COMMITTEE, AS SET FORTH IN DETAIL BELOW. A MEMBER MUST NOT PARTICIPATE IN ANY MATTER IN WHICH THAT MEMBER MAY HAVE AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST WITHOUT THE EXPRESS APPROVAL OF THE APPLICABLE ORGANIZATION'S BOARD OF DIRECTORS OR EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS (EXECUTIVE COMMITTEE). ALL MEMBERS MUST DISCLOSE TO THE APPLICABLE ORGANIZATION'S BOARD OF DIRECTORS OR EXECUTIVE COMMITTEE ALL CONFLICTS OF INTEREST AND REPORTABLE RELATIONSHIPS, AND MUST ANNUALLY COMPLETE AND SUBMIT THE CONFLICT OF INTEREST QUESTIONNAIRE WHICH IS REQUIRED BY THIS POLICY. WHENEVER IN THE COURSE OF EVENTS A MEMBER'S CIRCUMSTANCES CHANGE SUCH THAT THE MEMBER KNOWS OR HAS REASON TO BELIEVE THAT THE MEMBER MAY HAVE AN ACTUAL OR PERCEIVED CONFLICT OF INTEREST, SUCH MEMBER SHALL PROMPTLY DISCLOSE THE POTENTIAL CONFLICT TO THE APPLICABLE ORGANIZATION'S BOARD OF DIRECTORS OR EXECUTIVE COMMITTEE. FOR THE PURPOSES OF THIS ARTICLE, A MEMBER MAY FORMALLY DISCLOSE A CONFLICT OR REPORTABLE RELATIONSHIP TO THE CHIEF EXECUTIVE OFFICER (CEO) OF NMDP, THE BTMF EXECUTIVE DIRECTOR AND SENIOR VICE PRESIDENT (SVP) OF PHILANTHROPY, OR THE NMDP CHIEF LEGAL OFFICER (CLO), AS APPLICABLE, WHO SHALL INFORM THE APPLICABLE ORGANIZATION'S BOARD OF DIRECTORS OR EXECUTIVE COMMITTEE FOR RESOLUTION. AS NOTED HEREIN, IF THE POTENTIAL CONFLICT INVOLVES A DIRECTOR OR COMMITTEE MEMBER, THAT DIRECTOR OR COMMITTEE MEMBER SHALL NOT PARTICIPATE IN OR VOTE UPON SUCH MATTERS UNTIL THE QUESTION OF THE EXISTENCE OF THE CONFLICT OF INTEREST HAS BEEN RESOLVED IN ACCORDANCE WITH THIS POLICY. LIKEWISE, AN OFFICER OR KEY EMPLOYEE MAY NOT BECOME SUBSTANTIALLY INVOLVED IN DECISION-MAKING INVOLVING ANY COVERED LITIGATION, CONTRACT OR TRANSACTION UNTIL THE RESOLUTION OF THE MATTER IN ACCORDANCE WITH THIS POLICY." FORM 990, PART VI, SECTION B, LINE 15 PROCESS FOR DETERMINING COMPENSATION THE BTMF CHIEF ADVANCEMENT OFFICER REPORTS DIRECTLY TO THE NMDP CEO AND IS CONSIDERED A KEY EMPLOYEE PER THE IRS DEFINITION DURING FY2020. THE COMPENSATION OF THE BTMF CHIEF ADVANCEMENT OFFICER IS REVIEWED, EVALUATED, AND SET IN ACCORDANCE WITH THE NMDP BYLAWS AND COMPENSATION COMMITTEE CHARTER. THE NMDP BYLAWS STATE: "THE COMPENSATION COMMITTEE SHALL BE COMPRISED ONLY OF VOTING DIRECTORS AND SHALL INCLUDE THE CHAIR OF THE BOARD AND AT LEAST ONE (1) NON-OFFICER BOARD MEMBER AS VOTING COMMITTEE MEMBERS. THE COMPENSATION COMMITTEE SHALL REVIEW AND EVALUATE THE OVERALL COMPENSATION AND BENEFIT STRUCTURE OF THE CORPORATION AND SHALL HAVE SUCH OTHER AUTHORITY AND RESPONSIBILITIES AS SET FORTH IN THE COMPENSATION COMMITTEE CHARTER." THE COMPENSATION COMMITTEE CHARTER STATES: "THE COMMITTEE SHALL REVIEW AND EVALUATE THE OVERALL COMPENSATION AND BENEFIT STRUCTURE OF THE CORPORATION, AND APPROVE AND ADOPT A COMPENSATION PHILOSOPHY AND PRINCIPLES CONSISTENT WITH THE CORPORATION'S NOT-FOR-PROFIT STATUS (THE COMPENSATION PHILOSOPHY AND PRINCIPLES). THE COMMITTEE SHALL CONDUCT THE CHIEF EXECUTIVE OFFICER (CEO) PERFORMANCE EVALUATION. THE COMMITTEE SHALL MAKE CEO TOTAL COMPENSATION AND BENEFIT RECOMMENDATIONS TO THE EXECUTIVE COMMITTEE, CONSISTENT WITH THE COMPENSATION PHILOSOPHY AND PRINCIPLES. IN MAKING COMPENSATION AND BENEFIT RECOMMENDATIONS FOR THE CEO, THE COMMITTEE SHALL UTILIZE, AMONG OTHER THINGS, COMPARABILITY DATA FOR COMPLIANCE WITH IRS INTERMEDIATE SANCTION PROVISIONS SO AS TO ALLOW THE CORPORATION TO TAKE ADVANTAGE OF THE REBUTTABLE PRESUMPTION OF REASONABLENESS. ON A PERIODIC BASIS, THE COMMITTEE SHALL OBTAIN COMPARABILITY DATA FROM AN INDEPENDENT COMPENSATION CONSULTANT. IN ADDITION, THE COMMITTEE SHALL ADVISE THE CEO IN HIS/HER/THEIR EVALUATION OF AND DECISIONS REGARDING THE COMPENSATION OF AND BENEFITS FOR SENIOR CORPORATION EMPLOYEES, AS WELL AS THE PRESIDENT (OR EQUIVALENT LEADER) OF ANY SUBSIDIARY OF THE CORPORATION REPORTING TO THE CEO (TOGETHER, SENIOR LEADERSHIP). IN ADVISING THE CEO IN MAKING HIS/HER/THEIR COMPENSATION AND BENEFIT DECISIONS FOR SENIOR LEADERSHIP, THE COMMITTEE SHALL ENSURE THAT SUCH DECISIONS ARE CONSISTENT WITH THE COMPENSATION PHILOSOPHY AND PRINCIPLES, AND UTILIZE, AMONG OTHER THINGS, COMPARABILITY DATA FOR COMPLIANCE WITH IRS INTERMEDIATE SANCTION PROVISIONS. IF DECISIONS PROPOSED BY THE CEO ARE OUTSIDE THE PARAMETERS OF THE COMPENSATION PHILOSOPHY AND PRINCIPLES, THE CEO MUST OBTAIN THE COMMITTEE'S APPROVAL PRIOR TO IMPLEMENTATION." FORM 990, PART VI, SECTION C, LINE 19 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC THE CONFLICT OF INTEREST POLICY, ARTICLES OF INCORPORATION AND CONSOLIDATED AUDITED FINANCIAL STATEMENTS AND ADDITIONAL CONSOLIDATING INFORMATION ARE ALL MADE AVAILABLE TO THE PUBLIC UPON REQUEST. THE CONSOLIDATED AUDITED FINANCIAL STATEMENTS ARE ALSO AVAILABLE ON OUR WEBSITE. SUMMARY FINANCIAL STATEMENTS ARE ALSO INCLUDED IN OUR ANNUAL REPORT, WHICH IS MAILED TO KEY STAKEHOLDERS AND POSTED ON OUR WEBSITE. ADDITIONALLY, ARTICLES OF INCORPORATION ARE AVAILABLE AT THE MN OFFICE OF THE SECRETARY OF STATE, AND CONSOLIDATED AUDITED FINANCIAL STATEMENTS MAY BE OBTAINED AT THE MN OFFICE OF THE ATTORNEY GENERAL. FORM 990, PART VII, SECTION A, LINE 1A, COLUMN B HOURS FOR RELATED ORGANIZATION THE HOURS LISTED ON THE 990 PART VII ARE BASED ON A 50 HOUR WEEK THAT THESE INDIVIDUALS DEVOTED TO NMDP AND BTMF IN TOTAL DURING THE YEAR. NATIONAL MARROW DONOR PROGRAM 500 N 5TH ST MINNEAPOLIS MN 554011206 840865803 TRANSPLANTS CO 501(C)(3) LINE 10 N/A 0 BE THE MATCH MX AC VERACRUZ AV 93 101 PISO CUIDAD DE MEXICO CONDESA MX RECRUITMENT MX N/A N/A NMDP 0 BE THE MATCH BIOTHERAPIES SERVICES LLC 500 N 5TH ST MINNEAPOLIS MN 554011206 811248190 CELLULAR THERAPY MN NMDP C 0 CLEAR INSURANCE LTD (FORMERLY CLR) 62 FORUM LN 3RD FL PO BOX 30600 CJ KY1-1203 840865803 CAPTIVE INSURANCE CJ NMDP C 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 BE THE MATCH MX AC B 400000 FMV